VASH1 and lung carcinoma: The plasma VASH1 levels of patients according to lung cancer stages were as follows: IA 294.6 ± 147.4 fmol/mL; IB 297.7 ± 242.9 fmol/mL; IIA 290.9 ± 230.2 fmol/mL; IIB 271.3 ± 84.2 fmol/mL; and IIIA 259.8 ± 31.8 fmol/mL.